Why It's So Hard to Get a Monkeypox Vaccine Right Now

Brasil Notícia Notícia

Why It's So Hard to Get a Monkeypox Vaccine Right Now
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 TIMEHealth
  • ⏱ Reading Time:
  • 56 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 63%

Why It&039;s So Hard to Get a Monkeypox Vaccine Right Now

the country has enough vaccines in the Strategic National Stockpile . But many of the stockpiled ones are the older ACAM2000 vaccine, which is approved for use against smallpox and can also be used for monkeypox. It’s a live virus vaccine containing a virus that’s related to smallpox but milder. The shot causes a temporary sore at the injection site, which—if not properly cared for—can potentially spread the virus to unvaccinated people in close contact.

During a July 15 press briefing, U.S. Centers for Disease Control and Prevention Director Dr. Rochelle Walensky acknowledged that vaccine shortages are “frustrating” but said the administration is actively working to increase supply. Federal health officials will send more doses to jurisdictions that are seeing rising case rates, she said. New York, California, Illinois, Florida, Georgia, and Washington D.C.

But inadequate contact tracing and testing has made it hard to identify those who are infected and exposed, says Andrew Kilianski, an emerging infectious disease expert and adjunct professor at George Mason University. National testing capacity has increased from about 6,000 tests per week early in the outbreak to 70,000 now, according to federal health officials, but Kilianski says screening is still inadequate.

“When you’re thinking about just vaccinating contacts, that’s not going to be as much of a demand on the supply,” Adalja says. But if anyone who meets a few wide criteria and thinks they’re at risk can get vaccinated, “the demand is much higher than the supply.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

TIMEHealth /  🏆 121. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Why the bond market should be given the benefit of the doubtWhy the bond market should be given the benefit of the doubtHere are two reasons that the bond market’s rout has gone so far — that it will rally in coming months, columnist ​​MktwHulbert writes.
Consulte Mais informação »

Why are heatwaves dangerous and how does extreme heat affect the body?Why are heatwaves dangerous and how does extreme heat affect the body?Extreme heat brings serious health risks, especially for people who are elderly or have pre-existing conditions. Here’s what you need to know
Consulte Mais informação »

Why the Internet Is So Obsessed With Lea Michele Replacing Beanie Feldstein in Funny GirlWhy the Internet Is So Obsessed With Lea Michele Replacing Beanie Feldstein in Funny GirlThe answer manages to involve backstage drama, Glee parallels, ill-founded rumors, TikTok, and Babs.
Consulte Mais informação »

Why You Need To Build Your Life Pre-RelationshipWhy You Need To Build Your Life Pre-RelationshipHere, a licensed psychotherapist explains the one nonnegotiable for a healthy relationship. 💓
Consulte Mais informação »

EXPLAINER: Why US inflation is so high, and when it may easeEXPLAINER: Why US inflation is so high, and when it may easeEXPLAINER: Why US inflation is so high, and when it may ease KPRC2
Consulte Mais informação »

Why the party is over for Britain’s Research Excellence FrameworkWhy the party is over for Britain’s Research Excellence FrameworkMany UK universities pop the champagne when they get the results of a national research-performance review. But burnt-out academics see no cause for celebration, say Richard Watermeyer and Gemma Derrick.
Consulte Mais informação »



Render Time: 2025-02-25 18:23:03